Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Thomas Filleron"'
Autor:
Bastien Cabarrou, G. Ferron, Eberhard Stoeckle, E. Cohen-Jonathan Moyal, Christine Chevreau, Thibaud Valentin, S. Le Guellec, Justine Attal, Martine Delannes, Guillaume Vogin, B. Boulet, J P Nesseler, Thomas Filleron, Anne Ducassou
Publikováno v:
Strahlentherapie und Onkologie. 197:1051-1062
PURPOSE Patients with locally advanced grade 2-3 extremity/truncal soft tissue sarcomas (STS) are at high risk of recurrence. The objective of this study was to assess the efficacy and feasibility of neoadjuvant concurrent chemoradiotherapy (cCRT) in
Autor:
Leonor Chaltiel, Pierre Gazda, Benjamin Vairel, Thomas Filleron, Emilien Chabrillac, Agnès Dupret-Bories, Guillaume de Bonnecaze, Sébastien Vergez, Clément Gauche
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 279:457-466
Transoral robotic surgery (TORS) as a first-line therapy has been well-documented but evidence is missing regarding salvage therapy. The aim of this study is to compare the oncological and functional outcomes of TORS as a primary and salvage therapy.
Autor:
Jonathan Khalifa, Florence Dalenc, Eva Jouve, C. Massabeau, Raphaëlle Duprez-Paumier, Magali Lacroix Triki, Thomas Filleron
Publikováno v:
The Breast Journal. 22:510-519
The optimal management of patients with pathologically node-negative triple-negative breast cancer (pN0 TNBC) remains unclear. We hypothesized that lymph node irradiation (LNI; internal mammary chain/periclavicular irradiation) had an impact on outco
Autor:
G. Ferron, P. Morice, Frédéric Marchal, I. Jaffré, Michel Rivoire, Eric Lambaudie, G. Houvenaeghel, Denis Querleu, Eberhard Stoeckle, F. Foucher, Pierre Meeus, Sebastien Gouy, Thomas Filleron, J-M Classe, Pierre-Emmanuel Colombo, N. Chopin, Vincent Lavoué, Fabrice Narducci, Jean Levêque, Eva Jouve, Philippe Rouanet, Frédéric Guyon, Alejandra Martinez, J. L. Verheaghe, Eric Leblanc, A. Mourregot
Publikováno v:
Annals of Surgical Oncology
Annals of Surgical Oncology, 2018, 25 (2), pp.535-541. ⟨10.1245/s10434-017-6120-z⟩
Annals of Surgical Oncology, Springer Verlag, 2018, 25 (2), pp.535-541. ⟨10.1245/s10434-017-6120-z⟩
Annals of Surgical Oncology, 2018, 25 (2), pp.535-541. ⟨10.1245/s10434-017-6120-z⟩
Annals of Surgical Oncology, Springer Verlag, 2018, 25 (2), pp.535-541. ⟨10.1245/s10434-017-6120-z⟩
International audience; BACKGROUND:Pelvic exenteration remains one of the most mutilating procedures, with important postoperative morbidity, an altered body image, and long-term physical and psychosocial concerns. This study aimed to assess quality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::354c0544cbe96397cfcb83ecfcb83d28
https://hal.umontpellier.fr/hal-02290135
https://hal.umontpellier.fr/hal-02290135
Autor:
Roman K. Thomas, Oliver Gautschi, Julien Mazieres, Johannes M. Heuckmann, Sacha I. Rothschild, Fabrice Barlesi, Jürgen Wolf, Joachim Diebold, Pamela Biondani, Christian Spirig, L. Crinò, Gérard Zalcman, Damien Rouviere, Nicolas Pécuchet, Thomas Filleron, Julie Milia, Rafal Dziadziuszko, Anne-Marie C. Dingemans, Isabelle Monnet, Federico Cappuzzo, Benjamin Besse, Frauke Leenders, Luc Thiberville, Hervé Lena, Egbert F. Smit
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, 2015, 33 (9), pp.992-9
Journal of Clinical Oncology, American Society of Clinical Oncology, 2015, 33 (9), pp.992-9
Mazieres, J, Zalcman, G, Crino, L, Biondani, P, Barlesi, F, Filleron, T, Dingemans, A M C, Lena, H, Monnet, I, Rothschild, S I, Cappuzzo, F, Besse, B, Thiberville, L, Rouviere, D, Dziadziuszko, R, Smit, E F, Wolf, J, Spirig, C, Pecuchet, N, Leenders, F, Heuckmann, J M, Diebold, J, Milia, J D, Thomas, R K & Gautschi, O 2015, ' Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort ', Journal of Clinical Oncology, vol. 33, no. 9, pp. 992-999 . https://doi.org/10.1200/JCO.2014.58.3302
Journal of Clinical Oncology, 33(9), 992-999. American Society of Clinical Oncology
Journal of Clinical Oncology, 2015, 33 (9), pp.992-9
Journal of Clinical Oncology, American Society of Clinical Oncology, 2015, 33 (9), pp.992-9
Mazieres, J, Zalcman, G, Crino, L, Biondani, P, Barlesi, F, Filleron, T, Dingemans, A M C, Lena, H, Monnet, I, Rothschild, S I, Cappuzzo, F, Besse, B, Thiberville, L, Rouviere, D, Dziadziuszko, R, Smit, E F, Wolf, J, Spirig, C, Pecuchet, N, Leenders, F, Heuckmann, J M, Diebold, J, Milia, J D, Thomas, R K & Gautschi, O 2015, ' Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort ', Journal of Clinical Oncology, vol. 33, no. 9, pp. 992-999 . https://doi.org/10.1200/JCO.2014.58.3302
Journal of Clinical Oncology, 33(9), 992-999. American Society of Clinical Oncology
Purpose Approximately 1% of lung adenocarcinomas are driven by oncogenic ROS1 rearrangement. Crizotinib is a potent inhibitor of both ROS1 and ALK kinase domains. Patients and Methods In the absence of a prospective clinical trial in Europe, we condu
Autor:
Rosine Guimbaud, Thomas Filleron, Jannick Selves, Marine Humeau, Paulo Pereira, Nicolas Carrere, Laurent Ghouti
Publikováno v:
The American Journal of Surgery. 209:352-362
Background The benefits in terms of curative resection and survival of pelvic exenterations for specific extraluminal pelvic recurrences from rectal cancer in the era of total mesorectal excision were assessed. Methods We conducted a single-center re
Autor:
Anthony Al Hawat, Guillaume de Bonnecaze, Elie Serrano, Thomas Filleron, Sébastien Vergez, Benoit Chaput, Benjamin Vairel
Publikováno v:
Acta Oto-Laryngologica. 134:1259-1264
Endoscopic techniques seem to be safe approaches for the treatment of esthesioneuroblastomas (ENBs). However, they are intended for selected patients and require extensive experience in base of the skull surgery.ENB is a rare tumor of the nasal cavit
Autor:
Benoit Chaput, Thomas Filleron, G. De Bonnecaze, A. Al Hawat, Patrick Chaynes, Sébastien Vergez
Publikováno v:
Surgical and Radiologic Anatomy. 37:499-506
The temporal branch of the facial nerve, a particularly important branch in facial expression, is commonly exposed to surgical trauma. The frontal branch is the most important branch of the temporal branch in the clinical point of view. However, it d
Publikováno v:
The breast journal. 23(6)
Autor:
Joel W. Neal, Nir Peled, R. Camidge, Niki Karachaliou, Sebastian Michels, Jordi Remon-Masip, Thomas Muley, Robert C. Doebele, Vignhesh Narayanan, Dwight H. Owen, Benjamin Besse, Pasi A. Jänne, Heather A. Wakelee, Julie Milia, Jonathan W. Riess, Vamsidhar Velcheti, Martin Früh, Juergen Wolf, Isabelle Monnet, Rafael Rosell, Kristin Zeidler, Georg Pall, David R. Gandara, Tony Mok, Thomas Filleron, Chul Cho Byoung, Arne Warth, James Chih-Hsin Yang, Daniel D. Karp, Oliver Gautschi, Patrizia Froesch, Sanjay Popat, Joachim Diebold, Mark M. Awad, Alexander Drilon, Sacha I. Rothschild, Michael Van Den Heuvel, Florian Cabillic, Gérard Zalcman, Sai-Hong Ignatius Ou, David P. Carbone, Julien Mazieres, Jin-Yuan Shih
Publikováno v:
Journal of Clinical Oncology, 35, 13, pp. 1403-1410
Journal of Clinical Oncology, 35, 1403-1410
Journal of Clinical Oncology, 35, 1403-1410
Purpose In addition to prospective trials for non–small-cell lung cancers (NSCLCs) that are driven by less common genomic alterations, registries provide complementary information on patient response to targeted therapies. Here, we present the resu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3f74aa298eed586023f09f30b2abb17
https://hdl.handle.net/2066/177975
https://hdl.handle.net/2066/177975